The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Abbott's FreeStyle Libre CGM systems include sensors intended for placement on the back of the upper arm. The sensors may be ...

The recall does not affect users outside the U.S. or those using other FreeStyle Libre products such as the FreeStyle Libre ...

A new device from Abbott Laboratories, called Lingo, is geared toward people who don’t have diabetes but want to see how food ...

Abbott’s FreeStyle Libre will likely continue to see growth ... This resulted in a 5.6% rise in the bottom line to $1.14 on an adjusted basis. What It Means For ABT Stock? We think ABT stock ...

A major development towards the goal of patient and provider choice, the cloud-to-cloud integration will provide an automatic ...

Worldwide sales of the Freestyle Libre grew exponentially in 2019 ... Sarah, 42, from Northampton, has had Type 1 diabetes since she was 14. She has been back on finger prick testing for a ...

The device is similar to Abbott’s FreeStyle Libre, which people with diabetes have been using for years to track their glucose levels. Each disc remains on the arm for 14 days before it must be ...

Several products contributed to the strong performance, including FreeStyle Libre, Navitor, TriClip, Amplatzer Amulet, and AVEIR. In Electrophysiology, sales grew 12.2% on a reported basis and 14. ...

Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), The Procter & ...

As a result, their Freestyle Libre sales have been growing by 20% over ... debt $15 billion; and tax rate 14.5%. The DCF can be summarized as follows: Discounting all the future FCF, the fair ...

德康医疗一直是CGM（连续血糖监测）的龙头之一，但在很长时间里都没有解决价格昂贵的问题。自己也因为深耕内分泌医生（相当于国内的院内渠道，买通主治医生）花了不少销售费用，耽误了长达14年不盈利时间。